Perfromance Wealth Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$262K Sell
9,337
-175
-2% -$4.66K 0.01% 175
2025
Q4
$237K Buy
+9,512
New +$240K 0.01% 184
2025
Q3
Sell
-9,568
Closed -$232K 208
2025
Q2
$232K Sell
9,568
-222
-2% -$5.18K 0.01% 169
2025
Q1
$248K Buy
9,790
+1,534
+19% +$40.1K 0.01% 149
2024
Q4
$219K Sell
8,256
-693
-8% -$18.8K 0.01% 171
2024
Q3
$259K Sell
8,949
-2,224
-20% -$64.9K 0.01% 161
2024
Q2
$313K Buy
11,173
+1,373
+14% +$37.8K 0.01% 118
2024
Q1
$272K Sell
9,800
-1,106
-10% -$30.7K 0.01% 131
2023
Q4
$314K Sell
10,906
-1,408
-11% -$42.6K 0.01% 129
2023
Q3
$408K Sell
12,314
-1,500
-11% -$53K 0.02% 118
2023
Q2
$504K Buy
13,814
+3,722
+37% +$145K 0.02% 116
2023
Q1
$412K Sell
10,092
-1,552
-13% -$67K 0.02% 124
2022
Q4
$597K Sell
11,644
-897
-7% -$43K 0.04% 92
2022
Q3
$549K Sell
12,541
-47
-0.4% -$2.28K 0.03% 94
2022
Q2
$660K Sell
12,588
-634
-5% -$32.3K 0.04% 86
2022
Q1
$684K Buy
13,222
+1,236
+10% +$64.1K 0.03% 97
2021
Q4
$708K Buy
+11,986
New +$594K 0.03% 100

Other funds holding PFE

Perfromance Wealth Partners's PFE Position: Q1 2026 in Review

Perfromance Wealth Partners reduced its Pfizer (PFE) stake by 1.8% in Q1 2026, selling an estimated $4.66K and leaving 9,337 shares worth $262K. The position accounts for 0.01% of the portfolio, ranked #175.

Perfromance Wealth Partners first reported a position in PFE in Q4 2021 and has held it in 17 quarters since. The position peaked at $708K in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Perfromance Wealth Partners held 9,337 shares of Pfizer worth $262K as of Q1 2026.
  • Perfromance Wealth Partners sold 175 Pfizer shares in Q1 2026, an estimated $4.66K.
  • Pfizer made up 0.01% of Perfromance Wealth Partners's portfolio in Q1 2026, its #175 holding.
  • Perfromance Wealth Partners first reported a position in Pfizer in Q4 2021 and has held it in 17 quarters since.
  • Perfromance Wealth Partners's Pfizer position peaked at $708K in Q4 2021.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Perfromance Wealth Partners's 13F filing for Q1 2026, filed 10 Apr 2026.